Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
53.75
+0.50 (0.94%)
Last updated: Sep 10, 2025, 1:29 PM HKT

Sunshine Lake Pharma Company Description

Sunshine Lake Pharma Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.

It offers Kewei for the treatment of influenza; Dongweien for the treatment of hepatitis C; and generic drugs for the treatment of infections caused by sensitive bacteria, namely Clarithromycin, Levofloxacin, and Moxifloxacin Hydrochlorid, as well as active pharmaceutical ingredients.

The company also engages in the wholesale, retail, import, and export of drugs. The company was formerly known as Sunshine Lake Pharma Ltd. The company was incorporated in 2001 and is based in Dongguan, China.

Sunshine Lake Pharma Co., Ltd.
CountryChina
Founded2001
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees4,861
CEOWenjia Li

Contact Details

Address:
HEC Scientific Park
Dongguan
China
Websitehecpharm.com

Stock Details

Ticker Symbol6887
ExchangeHong Kong Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
SIC Code2834

Key Executives

NamePosition
Qiang Zhang CPAChief Financial Officer and Head of Finance Department
Qiyun PengJoint Company Secretary
Danjin WangDeputy General Manager
Shuang LiDeputy General Manager
Dr. Yingjun ZhangExecutive Chairman
Dr. Wenjia LiGM and Executive Director
Yangui ChenHead of the Sales Department
Shengchao WangChief of Quality Division and Employee Representative Supervisor
Wai Chiu Wong C.P.A., CTP, FCSJoint Company Secretary